5 Pharma Stocks Down More Than 70% From Their 52 Week High Levels

India is currently the world's largest supplier of generic medications, accounting for 20% of global supply by volume and roughly 60% of global demand for vaccines. Looking at present market conditions a do global affairs, the 2022 equity market is challenging. However, investing based on sector might be a good decision. Pharmaceuticals stocks amid the COVID times look promising investment. Here are the 5 pharma stocks that are trading below more than 70% from their 52 weeks high per share levels.

Earum Pharmaceuticals Ltd

Earum Pharmaceuticals was opened at Rs 4.70 on 9 June 2022. The current market price (CMP) of the stock is Rs 4.72 per share. The stock is 81.93% down from the 52 week of Rs 26.40. The stock's recorded 52 week low is Rs 4.51 per share. Its CMP is trading below Rs 21.68 per share from its 52 week high per share level and Rs 0.21 per share from its 52 week low per share levels. 
The stock has given negative returns in the last 1 month, 3 months, 6 months, and 1 year. However, on investment tenure of 5 years, it has given more than 30% positive returns. It has a market cap of Rs 28.93 crore. The stock is not listed on NSE. It is a BSE listed stock. 

Orchid Pharma Ltd

Orchid Pharma is an NSE listed company. Today it was opened at Rs 308/share, while the previous close was Rs 297.60/share. The Current market (CMP) of the stock is Rs 297 per share. The stock is trading 79.37% down from its 52 week high level of Rs 1,440 per share. Also, the stock is near 52 week low per share level of Rs 265 per share. Considering the CMP, it is trading at Rs 32 Per share above the 52 week low levels and Rs 1,143 down the 52 week high per share levels. 
The stock has given 4.65% positive returns in the last 3 months and a whopping 940.28% positive returns in the last 5 Years. The stock has not performed well in the last 1 month, 6 months and 1 year. 

Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences is also an NSE listed stock. Today it was opened at Rs 392.60/share. The previous close was Rs 388.70/share. The Current Market Price (CMP) of the stock is Rs 389.97. It is trading down 78.11% from its 52 week high of Rs 1,827 per share level. Considering its CMP and the 52 week high & low, it is trading above Rs 7.95 per share its 52 week low per share levels, and Rs 1,437.05 per share below ist 52 week high per share levels. The stock has recently hit the 52 week low at Rs 382 on 25 May 2022.

 The stock has given negative returns over the 3 year investment period on the equity investment, however, on 5 year investment period it has given more than 54% returns. Considering this, this stock could be a good long term investment for the investor's potential good returns.

Shree Ganesh Biotech India Ltd

Shree Ganesh Biotech India is a small-cap stock with a market capitalisation of Rs 101 Crore. The current market price of the stock is Rs 2.57 per share. The stock is near 77% down from the 52 week high level of Rs 11.30 per share. As per the CMP, the stock is trading at Rs 8.82 per share from its 52 week high of Rs 11.30, while Rs 0.08 per share above its 52 week low of Rs 2.40 per share levels. Though the company is reporting repeated profits, it is not paying out a dividend. Considering the positives, the company has reduced debt and is almost debt-free. The stock has given negative returns on equity over the last 5 years. However, today it is trading on a positive note. 

Bharat Immunological & Biologicals Corporation Ltd

Bharat Immunological and Biologicals Corporation is a Govt. of India Undertaking biotechnology company. The company is engaged in the manufacture of a Diarrhea management Kit, Zinc Tablets, Oral polio Vaccine, and BIB Sweet Tablets. The company is listed on BSE. 

The Current Market Price (CMP) of the stock is Rs 27.35 per share. It is trading below 71.06% from its 52 week high of Rs 94.50 per share level. The stock has also traded near its 52 week low level of Rs 26.65 per share. Considering the stock's CMP, it is below Rs 67.15 per share of 52 week high, and Rs 0.7 per share above its 52 week low. The stock is trading very close to its 52 week low levels. The company has had a negative return on equity of 22.68% for the last 3 months. Whereas, it has given positive returns of 232.32% in the last 3 years. In the last 5 years, it has given negative returns of 6.63% on equity investments.

 

5 Pharma Stock- CMP, Down (In %), 52 Week Low & High

Pharma Stocks	CMP	Down	52 Week Low	52 Week high
Earum Pharmaceuticals Ltd	Rs 4.72	81.93%	Rs 4.51	Rs 26.40
Orchid Pharma Ltd	Rs 297	79.37%	Rs 265	Rs 1,440
Solara Active Pharma Sciences Ltd	Rs 389.97	78.11%	Rs 382	Rs 1,827
Shree Ganesh Biotech India Ltd	Rs 2.57	77.00%	Rs 2.40	Rs 11.30
Bharat Immunological & Biologicals Corporation Ltd	Rs 27.35	71.06%	Rs 26.65	Rs 94.50

Disclaimer

The stock has been sourced from BSE & NSE. Greynium Information Technologies and the Author are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to check with certified experts before taking any investment decision.